Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session

Stock Markets Jul 01, 2022 17:40
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session

Gainers

  • Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday.
  • Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 49.3% to $0.2852. Allena Pharmaceuticals recently announced it has terminated its previously announced at-the-market offering.
  • Inter & Co, Inc. (NASDAQ: INTR) gained 31.9% to $2.77. Goldman Sachs (NYSE:GS) recently initiated coverage on the stock with a Sell rating.
  • Akebia Therapeutics, Inc. (NASDAQ: AKBA) gained 28% to $0.4521 after the company executed an agreement to terminate its vadadustat Collaboration and License Agreements with Otsuka Pharmaceutical. The company will receive a $55 million settlement fee.
  • Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares climbed 25.2% to $5.21. Lytus recently announced the closing of initial public offering.
  • ECMOHO Limited (NASDAQ: MOHO) rose 24.8% to $0.2049 after dropping over 4% on Thursday.
  • Fast Radius, Inc. (NASDAQ: FSRD) rose 22.3% to $0.7699 after jumping over 37% on Thursday. Fast Radius recently appointed Pat McCusker as President, Interim CFO and John Nanry as COO.
  • Larimar Therapeutics, Inc. (NASDAQ: LRMR) gained 20.9% to $2.37.
  • Shift Technologies, Inc. (NASDAQ: SFT) rose 20.1% to $0.8086 after declining around 7% on Thursday.
  • Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) surged 19.2% to $3.10.
  • VerifyMe, Inc. (NASDAQ: VRME) shares gained 18.6% to $2.3250 after the company announced liquidation of the G3 VRM Acquisition SPAC and initiated a new share repurchase program.
  • Accolade, Inc. (NASDAQ: ACCD) surged 18.2% to $8.74 after the company reported better-than-expected Q1 results.
  • Borqs Technologies, Inc. (NASDAQ: BRQS) jumped 17.3% to $1.9699 after the company announced its subsidiary, Holu Hou Energy, signed $49.8 million of contracts in Q2 in the State of Hawaii.
  • China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) gained 17.2% to $2.04.
  • Coupang, Inc. (NYSE: CPNG) gained 15.9% to $14.77 after Credit Suisse (SIX:CSGN) upgraded the stock from Neutral to Outperform.
  • Aspira Women's Health Inc. (NASDAQ: AWH) rose 14% to $0.6699.
  • LightInTheBox Holding Co., Ltd. (NYSE: LITB) gained 13% to $1.0850. LightInTheBox recently posted Q1 sales of $93.77 million.
  • Sonder Holdings Inc. (NASDAQ: SOND) shares surged 12.5% to $1.17.
  • Cosmos Holdings Inc. (NASDAQ: COSM) gained 12.1% to $0.4191. Cosmos Holdings reported a strategic R&D partnership with Cloudpharm P.C. to study the human gastrointestinal microbiome and launch related products targeting on obesity and other gut-related disorders.
  • Missfresh Limited (NASDAQ: MF) shares rose 11.1% to $0.2833 after declining around 10% on Thursday.
  • Engine Gaming and Media, Inc. (NASDAQ: GAME) gained 11.1% to $0.90.
  • Omeros Corporation (NASDAQ: OMER) rose 10.8% to $3.05.
  • Tenax Therapeutics, Inc. (NASDAQ: TENX) gained 10% to $0.3299.
  • Etsy, Inc. (NASDAQ: ETSY) surged 9.1% to $79.85. Evercore ISI Group maintained Etsy with an Outperform and lowered the price target from $130 to $95.
  • Missfresh Limited (NASDAQ: MF) gained 9% to $0.2780.
  • Synchronoss Technologies, Inc. (NASDAQ: SNCR) surged 8.3% to $1.2450.
  • OceanPal Inc. (NASDAQ: OP) rose 5% to $0.50. OceanPal recently announced entry into agreement to acquire capesize dry bulk vessel.
Losers
  • Talaris Therapeutics, Inc. (NASDAQ: TALS) shares dropped 49.4% to $2.28. SVB Leerink downgraded Talaris Therapeutics from Outperform to Market Perform and lowered the price target from $21 to $7.
  • Agile Therapeutics, Inc. (NASDAQ: AGRX) fell 44% to $0.6497 after the company priced a 26,666,666 share common stock offering at $0.90 per share.
  • ioneer Ltd (NASDAQ: IONR) fell 29% to $12.51.
  • Ensysce Biosciences, Inc. (NASDAQ: ENSC) fell 27.4% to $0.6305 after jumping around 73% on Thursday.
  • Kohl's Corporation (NYSE: NYSE:KSS) shares fell 21.3% to $28.10 after the company called off discussions to sell its business to Franchise Group Inc.
  • MMTec, Inc. (NASDAQ: MTC) dropped 20.8% to $0.2336.
  • Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares fell 20% to $0.5199 after jumping around 20% on Thursday.
  • Cryptyde, Inc. (NASDAQ: TYDE) dropped 18.2% to $1.66.
  • Borr Drilling Limited (NYSE: BORR) fell 18% to $3.78 after dropping 15% on Thursday.
  • Celldex Therapeutics, Inc. (NASDAQ: CLDX) fell 16.9% to $22.41 after the company presented interim data from its Barzolvolimab Phase 1b study at EAACI 2022.
  • Endo International plc (NASDAQ: ENDP) fell 14.4% to $0.3976 after the company announced topline results from its Phase 2 study of collagenase clostridium histolyticum (CCH) in participants with adhesive capsulitis (AC) of the shoulder (frozen shoulder).
  • Yoshitsu Co., Ltd (NASDAQ: TKLF) dropped 14.2% to $1.45.
  • Acutus Medical, Inc. (NASDAQ: AFIB) declined 14% to $0.9638. Acutus Medical recently announced the commercial launch of its left-heart access products.
  • ThermoGenesis Holdings, Inc. (NASDAQ: THMO) fell 13.3% to $0.2392.
  • Evofem Biosciences, Inc. (NASDAQ: EVFM) dropped 12.3% to $0.99.
  • Jiuzi Holdings, Inc. (NASDAQ: JZXN) fell 12.1% to $0.7713.
  • Kalera Public Limited Company (NASDAQ: KAL) dropped 10.4% to $5.28.
  • Amarin Corporation plc (NASDAQ: AMRN) fell 9.4% to $1.35. Amarin announced REDUCE-IT exploratory post hoc biomarker sub-analysis showed relatively small changes in inflammatory markers between icosapent ethyl and placebo.
  • Revelation Biosciences, Inc. (NASDAQ: REVB) fell 7.2% to $1.03 after jumping 77% on Thursday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for treatment of allergic rhinitis.
  • Biophytis S.A. (NASDAQ: BPTS) shares fell 7% to $1.00 after the company announced the drawing of the second tranche of Ornane under the 2021 Atlas contract for €4 million.
  • Micron Technology, Inc. (NASDAQ: NASDAQ:MU) fell 5.4% to $52.28. Micron reported upbeat financial results for its third quarter, but issued weak guidance for its fourth quarter.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session
 

Related Articles

Heron Shares Jump After Equity Financing, Q2 Earnings
Heron Shares Jump After Equity Financing, Q2 Earnings By Benzinga - Aug 09, 2022

Heron Therapeutics Inc (NASDAQ: HRTX) reported Q2 sales of $27.63 million, +23.1% Y/Y, beating the consensus of $24.31 million. Oncology sales reached $25.1 million, up from $22.4...

Sysco's Q4 Earnings Exceeds Street Expectations
Sysco's Q4 Earnings Exceeds Street Expectations By Benzinga - Aug 09, 2022

Sysco Corp (NYSE: NYSE:SYY) reported fourth-quarter FY22 sales growth of 17.5% year-on-year to $19 billion, beating the consensus of $18.21 billion. The U.S. Foodservice...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email